IDrugs 2003-05-01

SPM-927 (Schwarz Pharma).

Collin A Hovinga

Index: IDrugs 6(5) , 479-85, (2003)

Full Text: HTML

Abstract

Schwarz Pharma, under license from Harris FRC, is developing SPM-927, synthesized by researchers at the University of Houston, for the potential treatment of epilepsy and neuropathic pain.